Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vivitrol Coverage As Medical Benefit Expected To Be Advantageous

Executive Summary

Alkermes and Cephalon anticipate receiving reimbursement for their alcohol dependence therapy Vivitrol as a medical benefit

You may also be interested in...



Alkermes To Fly Solo On Vivitrol After Cephalon’s Departure

Biotech cites need to educate physicians about long-acting injectable for alcohol dependence.

Specialty Pharmacies Adopting PBM Formulary Management Practices

Pharmacy benefit manager formulary management practices are increasingly being used by specialty pharmacies, attendees said at the Pharmaceutical Care Management Association specialty pharmacy annual meeting in Palm Springs, Calif. Oct. 25

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

UsernamePublicRestriction

Register

PS047100

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel